GATTACO Inc. United States

GattaCo develops products that enable fast accurate evidence-based decision making to improve healthcare outcomes. We do this by solving the fundamental problems in sample purification, the most challenging component of the diagnostic testing workflow.

 Our new Plasm™ Module is a revolutionary, patented, automatic plasma separation and metering module or insert used to provide high-purity, metered plasma to a rapid diagnostic testing platform, such as lateral flow, biosensor, or other Point of Care (POC) device, from finger-stick capillary blood. The initial version of the Plasm Module is optimized for antibody testing and will revolutionize POC diagnostics by improving: 

  • Sensitivity: Increased number of antibodies compared to the same volume of whole blood.
  • Specificity Accuracy: High quality/purity sample with reduced background.
  • Repeatability: Plasma is metered to +/- 5%.
  • Quantitation: Precisely metered output, independent of hematocrit.
Website:
www.gattaco.com
Year of foundation
2018
Headquartner in China
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Michael McNeely
Pres/CEO 
Functionality

Geneception  Inc. China

Geneception is an innovation-driven biopharmaceutical company focusing on gene and cell therapy medicines.

Website:
N/A
Company Size (Fulltime employees)
Please specify your partnering goal
Gene therapy & cell therapy program
Headquartner in China
Biotech/Pharma Category
Dr. Amber Cai
CEO 
Functionality

GeneChem China

Company Size (Fulltime employees)
Year of foundation
2002
Please specify your partnering goal
Global partnership on Genechem preclinical assets
Headquartner in China
Biotech/Pharma Category
Assets Information 1
Claudin 6 Ab
Assets Information 2
Kras-TCRT
Biotech/Pharma Asset Stage
Dr. Tong Zhang
Chief Business Officer 

Genetron Health China

Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care. Genetron Health also partners with global biopharmaceutical companies and offers customized services and products.
Company Size (Fulltime employees)
Year of foundation
2015
Please specify your partnering goal
N/A
Headquartner in China
Mr. Evan Xu
Chief Financial Officer 
Functionality

GENOR China

Biopharm
Website:
www.genorbio.com
Partnering Objectives
Headquartner in China
Miao Gu
AD 

gensci China

gene company,.producing growth hormonr
Website:
gensci-china.com
Partnering Objectives
Headquartner in China
源 岳
转化医学高级研究员 

GenScript United States

GenScript is a global biotech company (Stock Code: 1548. HK) with 4,000 employees worldwide. Founded in 2002, GenScript business encompass four major categories in synthetic biology, protein analysis and purification, biologics development and manufacturing, and cell therapy.
Company Size (Fulltime employees)
Year of foundation
2002
Please specify your partnering goal
We are looking for partnering wtih companies provide platform/tools for protein ananlysis, purificaiton and cell separation.
Headquartner in China
Ms. Hong Qian
Head of Catalog Product Unit 
Functionality
Mr. Paul Kao
Mr. Paul Kao
VP, Business Development, Life Science Group 
Functionality

Genscript Biotech Corp United States

Founded in 2002, GenScript is committed to making humans and environment healthier through innovation. With its over 3,000 employees globally and R&D centers in the U.S., China and Europe, GenScript has become a global leader in providing research, biologics development services, synthetic biology products as well as a world class leader in cell therapy to help patients conquer serious diseases
Company Size (Fulltime employees)
Year of foundation
2002
Please specify your partnering goal
Strategic Partnership
Headquartner in China
Dr. Zhenyan Yan
VP Corporate Development 
Functionality

Hainan Haiyao Co. , Ltd China

Hainan Haiyao, a Chinese public company with stock code of 000566, is established in 1965, mainly focused on some severe diseases such as infection, tumor, digestion system etc.
Partnering Objectives
Headquartner in China
Min Zhou
BD Director 

Haisco Pharmaceutical group China

Haisco focus on the innovative drugs and the high-end drugs, and we seek collaborative partners for the previous drugs.
Website:
www.haisco.com
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
The partners develope the innovative and the high-end drugs.
Headquartner in China
Mrs. Echo Tang
BD manager 
Functionality